Personalis, Inc.
PSNL
Jodie situation report
Personalis, Inc.'s move is spreading beyond its market group.
No new filing conclusion is available. 12 of 21 group members are active now; 1 filing-linked outsider is moving with the group, and 0 of 28 directly disclosed connections are confirming.
- At least 14 of 21 members remain active in the next snapshot.
- Capital-flow agreement rises above 55%.
- IMMX remains aligned with the group in the next market snapshot.
Invalidation: The live read weakens if participation falls to 7 of 21 members or fewer.
Who this business touches
The relationships behind PSNL
Customers, suppliers, partners and competitors named in company filings—not inferred from headlines.
Depends on
MRNA25.0% of PSNLcustomerMay 7, 2026 ▾
“For example, we are providing genomic testing services to ModernaTX, Inc.”
NTRANatera, Inc.customerMay 7, 2026 ▾
“First Quarter 2026 Highlights Total revenue of $15.5 million decreased 25%, or $5.1 million, during the first quarter of 2026 compared to the first quarter of 2025, due to (i) lower revenue from pharma testing services and other customers; (ii) an expected re…”
Depended on by
CAICaris Life Sciences, Inc.competitorMar 3, 2026 ▾
“Our competitors in blood-based molecular profiling for MRD tracking and treatment monitoring include Natera, Guardant Health, SAGA Diagnostics, Personalis, BillionToOne, Quest Diagnostics and Adaptive Biotechnologies.”
Filing peers
Companies whose filings use similar operating language.
Open the three relationships above to see Jodie’s filing proof. Pro unlocks 29 more links, every receipt, and alerts when connected names begin moving. Unlock the full network →
What is moving around it
Live connections
PSNL is currently a Participant in the organic co-movement group Healthcare Innovators. This group is discovered from market behaviour rather than assigned from an industry taxonomy. 3 filing-linked names are in the relationship map; none is currently confirmed as moving with the group.